4.4 Article

Gut microbiome and pancreatic cancer cachexia: An evolving relationship

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Gut microbiota and metabolic aspects of cancer cachexia

Janine Ziemons et al.

Summary: Cancer cachexia is characterized by unintended weight loss and muscle wasting, with underlying mechanisms involving systemic inflammation and insulin resistance influenced by the gut microbiota. Preclinical studies support a role for gut microbiota in cachexia, demonstrating changes in microbiota composition, gut permeability, muscle atrophy, and positive effects of microbiota-modulating interventions. Data on the relationships between gut microbiota, insulin resistance, and hepatic/adipose tissue metabolism in cachexia models are lacking.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Microbiology

Analysis of mouse faecal dysbiosis, during the development of cachexia, induced by transplantation with Lewis lung carcinoma cells

Yara N. L. F. de Maria et al.

Summary: Cachexia, a wasting syndrome affecting cancer patients, is found to have different outcomes in gut dysbiosis depending on the induction mechanisms. A study using LLC cell inoculation in mice showed a more complex gut dysbiosis pattern compared to other induced models, with an expansion of Enterobacteriaceae observed.

MICROBIOLOGY-SGM (2021)

Article Geriatrics & Gerontology

Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients

Jorne Ubachs et al.

Summary: Cancer cachexia is a condition characterized by negative energy balance, muscle and adipose tissue wasting, insulin resistance, and systemic inflammation. This study found altered gut microbiota composition and decreased SCFA levels in cachectic cancer patients. Additionally, inflammatory parameters were found to be correlated with certain bacterial abundances.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)

Article Geriatrics & Gerontology

Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient-reported outcomes in pancreatic cancer cachexia

Gillian Gresham et al.

Summary: The study investigated the feasibility and efficacy of enteral tube feeding with a peptide-based formula in improving weight stability and patient-reported outcomes in advanced PDAC patients with cachexia. The findings suggest that this nutrition support may enhance weight stability, lean body mass, appendicular lean mass, and PROs in PDAC patients, highlighting the need for further larger and randomized controlled trials to validate these results.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)

Article Oncology

Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study

Nicolien C. de Clercq et al.

Summary: A study on fecal microbiota transplantation in cachectic patients with gastroesophageal cancer showed that allogenic FMT did not improve cachexia, but led to better disease control rate, overall survival, and progression-free survival. Patients in the allogenic group also experienced significant changes in fecal microbiota composition after FMT. This suggests a potential benefit of FMT in improving treatment response and survival in advanced gastroesophageal cancer patients.

CLINICAL CANCER RESEARCH (2021)

Article Ecology

Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients

Yueqiong Ni et al.

Summary: Our study revealed significant differences in gut microbial composition, functional pathways, and plasma metabolites between cachexia and non-cachectic patients, suggesting a potential influence of the gut microbiota on cachexia in a clinical setting.

ISME JOURNAL (2021)

Meeting Abstract Oncology

Fecal microbiome composition in pancreatic cancer cachexia and response to nutrition support.

Natalie Moshayedi et al.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Geriatrics & Gerontology

Understanding the gut microbiota and sarcopenia: a systematic review

Chaoran Liu et al.

Summary: This systematic review analyzed the evidence on the effects of gut microbiota on muscle/sarcopenia, showing that altering the gut microbiota can directly affect muscle phenotypes. Probiotics, prebiotics, short-chain fatty acids, and bacterial products are potential novel therapies to enhance muscle mass and physical performance. The potential mechanisms of microbiome modulating muscle include protein, energy, lipid, and glucose metabolism, inflammation level, neuromuscular junction, and mitochondrial function.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)

Article Oncology

A prospective trial of elemental enteral feeding in patients with pancreatic cancer cachexia (PANCAX-1).

Andrew Eugene Hendifar et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Review Microbiology

Microbiota and cancer: host cellular mechanisms activated by gut microbial metabolites

Sofia A. Tsvetikova et al.

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2020)

Review Environmental Sciences

The Gut Microbiota and Inflammation: An Overview

Zahraa Al Bander et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Article Gastroenterology & Hepatology

Oral microbiome and pancreatic cancer

Ai-Lin Wei et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2020)

Letter Gastroenterology & Hepatology

Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal adenocarcinoma

Jun Gong et al.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2020)

Review Immunology

Inflammation and Cancer: Triggers, Mechanisms, and Consequences

Florian R. Greten et al.

IMMUNITY (2019)

Editorial Material Critical Care Medicine

Less is more in nutrition: critically ill patients are starving but not hungry

Yaseen M. Arabi et al.

INTENSIVE CARE MEDICINE (2019)

Review Immunology

Targeting the Gut Microbiota to Treat Cachexia

Laurence Genton et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)

Article Oncology

Pancreas Cancer-Associated Weight Loss

Andrew E. Hendifar et al.

ONCOLOGIST (2019)

Article Oncology

Cachexia, and not obesity, prior to pancreatic cancer diagnosis worsens survival and is negated by chemotherapy

Andrew E. Hendifar et al.

JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)

Review Oncology

Meta-analyses of treatment standards for pancreatic cancer

Jun Gong et al.

MOLECULAR AND CLINICAL ONCOLOGY (2016)

Article Nutrition & Dietetics

Cachexia: clinical features when inflammation drives malnutrition

Alessandro Laviano et al.

PROCEEDINGS OF THE NUTRITION SOCIETY (2015)

Review Medicine, General & Internal

Programmed cell death and its role in inflammation

Yong Yang et al.

MILITARY MEDICAL RESEARCH (2015)

Article Physiology

Pancreatic cancer cachexia: a review of mechanisms and therapeutics

Carlyn R. Tan et al.

FRONTIERS IN PHYSIOLOGY (2014)